Promising efficacy and tolerability in this small cohort of patients with treatment-resistant AD Dual Therapy for Atopic Dermatitis: Lebrikizumab and JAK Inhibitors Used in Tandem for Treatment-Resistant Cases from the...
JDD Review Examines Malassezia Folliculitis and Diagnostic Challenges for Clinicians This is a must-read article from JDD. A narrative review in the Journal of Drugs in Dermatology summarizes current evidence...
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Darrell S. Rigel MD MS, one of the co-authors of A Randomized Controlled Trial Analyzing the Likeability, Usability,...
Curated by the JDD Editors Missed any of our June highlights? June is our Acne and Rosacea issue and is packed with intriguing articles, and you’ll want to start to...
Promising efficacy and tolerability in this small cohort of patients with treatment-resistant AD Dual Therapy for Atopic Dermatitis: Lebrikizumab and JAK Inhibitors Used in Tandem for Treatment-Resistant Cases from the...
JDD Review Examines Malassezia Folliculitis and Diagnostic Challenges for Clinicians This is a must-read article from JDD. A narrative review in the Journal of Drugs in Dermatology summarizes current evidence...
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Darrell S. Rigel MD MS, one of the co-authors of A Randomized Controlled Trial Analyzing the Likeability, Usability,...
Curated by the JDD Editors Missed any of our June highlights? June is our Acne and Rosacea issue and is packed with intriguing articles, and you’ll want to start to...
